Heinz Gisslinger

机构：Medical University of Vienna · ORCID：0000-0002-0295-7629

发表论文 444 篇 · 总被引 27124 次 · h-index 75

代表论文

• Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment (2023 · Leukemia · 被引 78)
• Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis (2024 · Blood · 被引 27)
• The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients (2023 · Blood Cancer Journal · 被引 18)
• Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera (2025 · Blood Cancer Journal · 被引 12)
• Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcome (2024 · Hematology · 被引 8)
• Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study (2023 · European Journal Of Haematology · 被引 5)